drugset / Trial / NCT04078659

Propofol and Magnesium Sulfate Intravenous Infusion During Endoscopic Sinus Surgery

NCT04078659

Unknown 50 enrolled Mansoura University
RandomizedParallel-groupSingle-blindSupportive care

Summary

Endoscopic Sinus surgery usually associated by bleeding, despite using of local vasopressor injection, head up position- controlled hypotension is generally used for control of this purpose. Propofol has been reported as a good agent for controlled hypotension by decreasing systemic vascular resistance secondary to arterial and venous vasodilation and a decrease in myocardial contractility with a dose-dependent property. Magnesium Sulfate also has been reported as an agent of hypotensive anaesthesia by inhibition of the release of norepinephrine by blocking N-type calcium channel at the nerve ending beside acting as a vasodilator. The well known pharmacodynamic effects of the intravenous infusion of propofol or Magnesium Sulfate may prove the advantage of this group in controlling intraoperative blood pressure thus reducing surgical field bleeding.

Timeline

Start
2019-09
Primary completion
2020-01
Completion
2020-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 10 mg/kg Intravenous
Subject Magnesium Sulfate Other / unclassified 15 mg/kg Intravenous
Subject Propofol Small molecule 50 ug/kg Intravenous
Subject Propofol Small molecule 1 mg/kg Intravenous
Subject Propofol Small molecule 2 mg/kg Intravenous
Background Atracurium Small molecule 0.6 mg/kg Intravenous
Background Fentanyl Other / unclassified 1 ug/kg
Background Fentanyl Other / unclassified 2 ug/kg
Background Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications

No indication recorded.